Table 2: CLE performance.

Reference

Year

Pathology

Total no. patients/lesions

Sensitivity

Specificity

Accuracy

Canto, et al. [40]

2014

EAC

192 patients; 978 biopsy specimens

96%

92%

93%

Sharma, et al. [41]

2011

EAC

101 patients

68.30%

87.80%

 

Pech, et al. [42]

2008

ESCC

27 patients

100%

87%

95%

Huang, et al. [43]

2015

ESCC

52 patients

95.70%

90%

97.80%

Kitabatake, et al. [44]

2006

Gastric cancer

27 patients; 57 sites

82-91%

98%